HOMIDIUM TABLET FOR INJECTION

Indications

• Trypanosomiasis
• Sleeping sickness

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines.

Adults: Refer to the BNF for specific dosing guidelines.

Mechanism of action

Homidium acts by inhibiting the synthesis of nucleic acids in the protozoan organisms responsible for trypanosomiasis. It interferes with DNA and RNA synthesis, ultimately leading to the death of the protozoan cells. Its mechanism involves the inhibition of the enzyme topoisomerase, which is crucial for DNA replication.

Pharmacodynamics

The pharmacodynamics of homidium involve its ability to disrupt cellular processes in trypanosomes, leading to antiparasitic effects. The drug exhibits a selective toxicity for the protozoan cells over mammalian cells, making it effective in treating infections caused by these parasites while minimizing harm to the host.

Pharmacokinetics

Homidium is well absorbed following administration, with a distribution that allows it to penetrate various tissues, including the central nervous system. The drug is metabolized in the liver and excreted primarily through the kidneys. Its half-life can vary depending on the route of administration and the specific formulation used.

Pregnancy

There is limited data on the use of homidium in pregnant women. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether homidium is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat.